Gene Editing Market By Product Type (Reagents, Enzymes, Kits and Software), By Application (Biomedical Research, Agriculture, Industrial Biotechnology, Gene Therapy and Diagnostics), By Technology (CRISPR, TALEN, ZFN, Meganucleases, Prime Editing, Other Techniques), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs) and Agricultural Companies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Nov 2024 | Report ID: MI1240 | 220 Pages
Report Coverage:
By Product Type
- Reagents
- Enzymes
- Kits
- Software
By Application
- Biomedical Research
- Agriculture
- Industrial Biotechnology
- Gene Therapy
- Diagnostics
By Technology
- CRISPR
- TALEN
- ZFN
- Meganucleases
- Prime Editing
- Other Techniques
End-User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutions
- Contract Research Organizations (CROs)
- Agricultural Companies
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Vertex Pharmaceuticals
- Sangamo Therapeutics
- Abeona Therapeutics
- Cellectis
- Caribou Biosciences
- Regeneron Pharmaceuticals
- Beam Therapeutics
- Novartis
- Amgen
- Thermo Fisher Scientific
- Agilent Technologies
- Lonza Group
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.